Psomagen, Inc. (KOSDAQ:950200)
South Korea · Delayed Price · Currency is KRW 3,400.00
-150.00 (-4.23%)
At close: Apr 1, 2026
Psomagen Market Cap
Psomagen has a market cap or net worth of 65.4 billion as of April 1, 2026. Its market cap has decreased by -12.48% in one year.
Market Cap
65.40B
Enterprise Value
66.71B
Revenue
55.98B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,400.00
Market Cap Chart
Since July 13, 2020, Psomagen's market cap has decreased from 254.61B to 65.40B, a decrease of -74.31%. That is a compound annual growth rate of -21.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 65.40B | -12.37% |
| Dec 30, 2025 | 74.64B | -4.20% |
| Dec 30, 2024 | 77.91B | -20.59% |
| Dec 28, 2023 | 98.10B | -34.17% |
| Dec 29, 2022 | 149.03B | -12.38% |
| Dec 30, 2021 | 170.10B | -50.35% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Choong Ang Vaccine Laboratory | 85.60B |
| Shaperon | 77.97B |
| Aptamer Sciences | 74.31B |
| PanGen Biotech | 73.00B |
| Naturalendo Tech | 69.93B |
| Ark Solutions | 68.91B |
| HLB Pep | 67.47B |
| EyeGene | 65.93B |